
: ‘Pushpa’ composer Devi Sri Prasad keeps it simple: ‘Even a dance song needs a catchy tune’ #IndiaNEWS Pushpa wasn’t the only one rising.Sukumar’s Telugu-language Pushpa: The Rise has been
‘Pushpa’ composer Devi Sri Prasad keeps it simple: ‘Even a dance song needs a catchy tune’ #IndiaNEWS
Pushpa wasn’t the only one rising.Sukumar’s Telugu-language Pushpa: The Rise has been a success in its Hindi version. Which means a wider audience for hit-maker Devi Sri Prasad.Prasad’s catchy melodies, dance numbers and crisp production have adorned a series of Telugu blockbusters. When the movies are dubbed in Hindi, his songs are among the highlights, such as Ringa Ringa (Arya 2), reworked as Dhinka Chika for Salman Khan’s Ready and Aa Ante Amalapuram (Arya), featured in the Hindi-language Maximum (2012).Gudilo Badilo from DJ: Duvvada Jagannadham clicked with a national audience after the Hindi version reportedly clocked 10 crore views in record time on YouTube. All three songs feature Allu Arjun, making Prasad a key contributor to the Telugu star’s popularity. Arjun, who plays a smuggler in Pushpa: The Rise, once again has Prasad’s pulsating tunes for company. If the feral Daakko Daakko Meka has Pushpa explaining his dog-eat-dog philosophy, he turns Romeo with the sweet Srivalli, sung by Sid Sriram. Devi Sri Prasad’s mastery of the soundscape of the Telugu star vehicle has similarly worked for Chiranjeevi, Pawan Kalyan, NTR Jr, Nagarjuna and Prabhas. The 42-year-old composer’s success has also benefitted Tamil actors such as Kamal Haasan, Vijay, Suriya, Vikram, Karthi and Dhanush. Prasad’s influence extends to Bollywood: after Ready, Salman Khan rehashed...Read more
Latest stock market news Twitter alternate of India
0 Reactions React
More posts by @newsMNC

: Bangladesh’s qualified accountants could help start a BPO boom in the country #IndiaNEWS Hiring certified professional accountants is no cut-rate task in London, one of the world’s three financial
0 Reactions React

: No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose #IndiaNEWS Vaccine maker Bharat Biotech has not provided any data on the efficacy of the Covaxin
0 Reactions React
0 Comments
Sorted by latest first Latest Oldest Best
Terms of Use Create Support ticket Your support tickets Stock Market News! © babycheers.com2025 All Rights reserved.